Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Kamai, Takao ^a   Yanai, Yoshiaki ^b   Arai, Kyoko ^a   Abe, Hideyuki ^a   Yamanishi, Tomonori ^a   Kurimoto, Masashi ^b   Yoshida, Ken Ichiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 2; MESSENGER RNA; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; IFNAR1 PROTEIN, HUMAN; IFNAR2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; UNSPECIFIED SIDE EFFECT; WESTERN BLOTTING; GENETICS; KIDNEY TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, INTERFERON ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE;

EID: 34748904736     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-159     Document Type: Article

References (23)

1. Motzer RJ Bander NH Nanus DM Renal-cell carcinoma N Engl J Med 1996, 335:865-875. 10.1056/NEJM199609193351207 8778606
2. Yagoda A Petrylak D Thompson S Cytotoxic chemotherapy for advanced renal cell carcinoma Urol Clin North Am 1993, 20:303-321. 8493752
3. Yagoda A Abi-Rached B Petrylak D Chemotherapy for advanced renal-cell carcinoma: 1983-1993 Semin Oncol 1995, 22:42-60. 7855619
4. Motzer RJ Russo P Nanus DM Berg WJ Renal cell carcinoma Current Problem Cancer 1997, 21:189-232.
5. Mogensen KE Lewerenz M Reboul J Lutfalla G Uze G The type I interferon receptor: Structure, function, and evolution of a family business J Interferon Cytokine Res 1999, 19:1069-1098. 10.1089/107999099313019 10547147
6. Ota H Nagano H Sakon M Eguchi H Kondo M Yamamoto T Nakamura M Damdinsuren B Wada H Marubashi S Miyamoto A Dono K Umeshita K Nakamori S Wakasa K Monden M Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression Br J Cancer 2005, 93:557-564. 10.1038/ sj.bjc.6602742 16106266
7. Kondo M Nagano H Wada H Damdinsuren B Yamamoto H Hiraoka N Eguchi H Miyamoto A Yamamoto T Ota H Nakamura M Marubashi S Dono K Umeshita K Nakamori S Sakon M Monden M Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells Clin Cancer Res 2005, 11:1277-1286. 10.1158/1078-0432.CCR-05-0274 15709199
8. Kamai T Tsujii T Arai K Takagi K Asami H Ito Y Oshima H Yoshida K-I Significant association of Rho/ROCK pathway withinvasion and metastasis of bladder cancer Clin Cancer Res 2003, 9:2632-2641.12855641
9. Suwa H Ohshio G Imamura T Watanabe G Arii S Imamura M Narumiya S Hiai H Fukumoto M Overexpression of the rho C gene correlates with progression of ductal adenocarcinoma of the pancreas Br J Cancer 1998, 77:147-152. 9459160
10. Kamai T Arai K Tsujii T Honda M Yoshida K-I Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour BJU Int 2001, 87:227-231. 10.1046/j.1464-410x.2001.02030.x 11167647
11. Sobin H Wittekind CH editors International union against cancer. UICC TNM classification of malignant tumors New York, Wiley-Liss 6 2002
12. Tochizawa S Akamatsu S Sugiyama Y Nuraguchi M Ohmoto T Ono Y Ishikawa H Tanigami A Sumida T Mori T A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets J Pharmacol Toxicol Methods 2004, 50:59-66. 10.1016/ j.vascn.2004.02.003 15233969
13. Ohata K Yano K Yatsuhashi H Daikoku M Koga M Eguchi K Yano M Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C Dig Dis Sci 2004, 49:289-294. 10.1023/ B:DDAS.0000017453.79349.46 15104372
14. Fritz G Just I Kaina B Rho GTPase over-expressed in human tumors Int J Cancer 1999, 81:682-687. 10.1002/ (SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B 10328216
15. Morell-Quadreny L Fenollosa-Entrena B Clar-Blanch F Navarro-Fos S Llombart-Bosch A Expression of type I interferon receptor in renal cell carcinoma Oncol Rep 1999, 6:639-642. 10203606
16. Motzer RJ Mazumdar M Bacik J Berg W Amsterdam A Ferrara J Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma J Clin Oncol 1999, 17:2530-2540. 10561319
17. Motzer RJ Bacik J Murphy BA Russo P Mazumdar M Interferon-alpha as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma J Clin Oncol 2002, 20:289-296. 10.1200/ JCO.20.1.289 11773181
18. Messing EM Manola J Wilding G Propert K Fleischmann J Crawford ED Pontes JE Hahn R Trump D Eastern Cooperative Oncology Group/Intergroup trial Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: An Eastern Cooperative Oncology Group/ Intergroup trial J Clin Oncol 2003, 21:1214-1222. 10.1200/ JCO.2003.02.005 12663707
19. Horiguchi A Oya M Shimada T Uchida A Marumo K Murai M Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: A study of incidence and its association with pathological features and clinical outcome J Urol 2002, 168:762-765. 10.1016/ S0022-5347(05)64741-6 12131365
20. Horiguchi A Oya M Uchida A Marumo K Murai M Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma J Urol 2003, 169:710-713. 10.1016/S0022-5347(05)63998-5 12544348
21. Kotenko SV Izotova LS Mirochnitchenko OV Lee C Pestka S The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation Proc Natl Acad Sci U A 2002, 96:5007-5012. 10.1073/pnas.96.9.5007
22. Velichko S Wagner TC Turkson J Jove R Croze E STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues J Biol Chem 2004, 4(2):97-105. 10.1074/jbc.M204578200 12105218
23. Yu H Jove R The stats of cancer - New molecular targets come of age Nature Rev Cancer 2004 4(2): 97-105